Inactive Instrument

Press Releases Progenics Pharmaceuticals, Inc.

Equities

US7431871067

Press Releases

Unlock all the news: Be the first to know and act before the market!

PROGENICS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	20-06-22	AQ
Progenics Pharmaceuticals : Lantheus Completes Merger with Progenics	20-06-22	BU
PROGENICS PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	20-06-17	AQ
PROGENICS PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	20-06-16	AQ
Progenics Stockholders Approve Merger with Lantheus	20-06-16	GL
PROGENICS PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)	20-06-11	AQ
PROGENICS PHARMACEUTICALS INC : Other Events (form 8-K)	20-06-08	AQ
PROGENICS PHARMACEUTICALS INC : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	20-05-28	AQ
WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.	20-05-27	PR
Progenics Pharmaceuticals : to Present Results from the Phase 3 CONDOR Trial of PyL in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program	20-05-19	AQ
PROGENICS PHARMACEUTICALS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-05-18	AQ
Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program	20-05-18	GL
PROGENICS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	20-05-07	AQ
Progenics: 1Q Earnings Snapshot	20-05-07	AQ
PROGENICS PHARMACEUTICALS INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-05-07	AQ
Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update	20-05-07	GL
Progenics Pharmaceuticals Sets First Quarter 2020 Financial Results and Business Update Call for May 7	20-04-23	GL
Lantheus : Velan Capital Agrees to Support Merger of Lantheus and Progenics	20-04-15	AQ
PROGENICS PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	20-04-14	AQ
Progenics Pharmaceuticals : ADDING MULTIMEDIA Velan Capital Agrees to Support Merger of Lantheus and Progenics	20-04-14	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Progenics Pharmaceuticals, Inc.

Equities

US7431871067

Press Releases

Filters